ONCIRE Trademark

Trademark Overview


On Friday, June 17, 2016, a trademark application was filed for ONCIRE with the United States Patent and Trademark Office. The USPTO has given the ONCIRE trademark a serial number of 79188740. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, May 12, 2023. This trademark is owned by Novartis AG. The ONCIRE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
oncire

General Information


Serial Number79188740
Word MarkONCIRE
Filing DateFriday, June 17, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, May 12, 2023
Registration Number5070824
Registration DateTuesday, November 1, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 16, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics
Translation of Words in MarkThe wording "ONCIRE" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Sunday, February 18, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Monday, January 29, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, January 29, 2024INVALIDATION PROCESSED
Friday, January 12, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, May 12, 2023CANCELLED SECTION 71
Friday, December 16, 2016NOTIFICATION PROCESSED BY IB
Thursday, December 1, 2016FINAL DISPOSITION NOTICE SENT TO IB
Thursday, December 1, 2016FINAL DISPOSITION PROCESSED
Thursday, December 1, 2016GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Friday, November 25, 2016NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, November 1, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, August 16, 2016PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 10, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 27, 2016NOTICE OF PUBLICATION
Friday, July 15, 2016APPLICATION FILING RECEIPT MAILED
Tuesday, July 12, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 11, 2016ASSIGNED TO EXAMINER
Monday, July 11, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 8, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 7, 2016SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB